Factors Associated With Off-Label Oncology Prescriptions: The Role of Cost and Financing in a Universal Healthcare System

Purpose: Various solutions have been put forward for prescribing and reimbursing treatments outside their registered indications within universal healthcare systems. However, most off-label oncology prescriptions are not reimbursed by health funds. This study characterized the financing sources of o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Noa, Goldstein, Daniel A., Tadmor, Boaz, Stemmer, Salomon M., Greenberg, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560680/
https://www.ncbi.nlm.nih.gov/pubmed/34737706
http://dx.doi.org/10.3389/fphar.2021.754390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560680/
https://www.ncbi.nlm.nih.gov/pubmed/34737706
http://dx.doi.org/10.3389/fphar.2021.754390

Ejemplares similares